2014 CPhI Preview - Ash Stevens - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

2014 CPhI Preview - Ash Stevens


2014 CPhI Exhibitor Preview

Company: Ash Stevens

Description: Ash Stevens is a global provider of contract drug substance development and active pharmaceutical ingredient (API) manufacturing with more than 50 years of experience. Services offered by Ash Stevens include process development, analytical and regulatory support, QbD services, document support for submissions, and commercial cGMP manufacturing including potent compound handling.

Website: www.ashstevens.com

Booth Number: 3C100

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here